| Jun 10 2015 |
NDRC Issued Opinions and Notice on Drug Price Reform: National Development and Reform Commission |
Sheppard, Mullin, Richter & Hampton LLP |
| Jun 9 2015 |
Positive Workplace Drug Test Results On The Rise For Second Straight Year, Study Finds |
Jackson Lewis P.C. |
| Jun 9 2015 |
FDA Finally Releases Initial Framework for Food Importation “VQIP”: Voluntary Qualified Importer Program |
Mintz |
| Jun 9 2015 |
State Action May Block Big Savings on Biosimilars |
Mintz |
| Jun 9 2015 |
Zofran Studies Link Medication to Serious Health Risks |
Stark & Stark |
| Jun 9 2015 |
Federal Circuit Finds Nunc Pro Tunc Agreement Does Not Confer Standing |
Foley & Lardner LLP |
| Jun 9 2015 |
FDA Issues Draft Guidance on Voluntary Qualified Importer Program Under the Food Safety Modernization Act |
Barnes & Thornburg LLP |
| Jun 8 2015 |
Voluntary Qualified Importer Program Draft Guidance: Incentivizing Food Import Safety |
Morgan, Lewis & Bockius LLP |
| Jun 7 2015 |
Federal Circuit Hears Oral Arguments in Litigation involving the First U.S. Biosimilar Product |
Michael Best & Friedrich LLP |
| Jun 7 2015 |
Brazil’s New Biodiversity Law |
Michael Best & Friedrich LLP |
| Jun 6 2015 |
Scrutiny of Nail Salon Chemicals Raises Mass Tort Risk |
ArentFox Schiff LLP |
| Jun 5 2015 |
SAMHSA Seeks Comments on Hair Testing For Drugs - Substance Abuse and Mental Health Services Administration |
Jackson Lewis P.C. |
| Jun 5 2015 |
USDA Proposed Rule Limits Payments to Non-Farmers |
Varnum LLP |
| Jun 4 2015 |
Catch of the Day: Tuna Fish Brand StarKist Swims into a Sea of Trouble After Agreeing to Settle Claims Against It |
Proskauer Rose LLP |
| Jun 4 2015 |
The Federal Circuit’s First Foray into the BPCIA: “A Pulitzer Prize for Complexity”? |
Mintz |
| Jun 4 2015 |
Act II: Oral Argument in Amgen v. Sandoz is heard at the Court of Appeals for the Federal Circuit |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
| Jun 4 2015 |
New USDA Study Says COOL not Beneficial to American Consumers - Country-of-Origin Labeling |
Varnum LLP |
| Jun 4 2015 |
Second Circuit Holds a Hard Switch Between Drugs Is an Unlawful Product Hop Under Section 2 |
Mintz |
| Jun 4 2015 |
Federal Circuit Hears Oral Arguments in Neupogen Biosimilar Case |
Foley & Lardner LLP |
| Jun 3 2015 |
Multiple DWI Convictions Don’t Create A “Record of” Alcoholism Under ADA; Driving Restrictions Don’t Support “Regarded As” Claim |
Jackson Lewis P.C. |
| Jun 2 2015 |
Big Win for Anti-GMO Groups as Oregon Federal Judge Upholds Jackson County GMO Ban |
Mintz |
| Jun 2 2015 |
FTC’s $1.2 Billion Disgorgement Settlement With Cephalon: Heightened Scrutiny of Hatch-Waxman Settlements |
Foley & Lardner LLP |
| Jun 2 2015 |
New Regulations in the Administration of Buprenorphine, Part One |
McBrayer, McGinnis, Leslie and Kirkland, PLLC |
| Jun 2 2015 |
Cosmetic Safety Legislation Introduced, Again |
Beveridge & Diamond PC |
| Jun 2 2015 |
Another Sequenom Patent Appeal Heads To The Federal Circuit |
Foley & Lardner LLP |
| Jun 2 2015 |
Second Circuit Requires Manufacturer to Continue Selling Old Version of Drug to Prevent Anticompetitive "Product Hopping" |
ArentFox Schiff LLP |
| Jun 2 2015 |
Medical Marijuana and Gaming: To Divest or Not to Divest? |
Dickinson Wright PLLC |
| Jun 1 2015 |
In Affirming a Preliminary Injunction Against Drug Companies, Second Circuit Finds Coercion in Product Hopping Scheme |
American University Washington College of Law |
| May 30 2015 |
FDA Poised to Ban Most Trans Fats |
ArentFox Schiff LLP |
| May 29 2015 |
Italian Competition Authority Launches Sector Inquiry in Re: Vaccines For Human Use |
Covington & Burling LLP |
| May 28 2015 |
GMOs at the Ballot Box: the Drama Continues |
Mintz |
| May 27 2015 |
FDA Issues Draft Guidance on Use of Patient Preference Information in Certain Medical Device Pre-market Submissions and Labeling |
Barnes & Thornburg LLP |
| May 27 2015 |
FDA Issues Draft Guidance on Mandatory Food Recalls Under the Food Safety Modernization Act |
Barnes & Thornburg LLP |
| May 27 2015 |
Dependent Claims Give Rise To Improper Broadening Reissue re: Patent Applications |
Foley & Lardner LLP |
| May 26 2015 |
House Subcommittee Circulates Proposed Legislation Providing Insight on the Future of the 340B Drug Pricing Program |
McDermott Will & Emery |
